Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,762 | -2,897 | -1,553 | -613 | -5,810 |
| Depreciation Amortization | 40 | 29 | 15 | 101 | 77 |
| Income taxes - deferred | -1,459 | -973 | -419 | -6,880 | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | 21 |
| Other Working Capital | -71 | -210 | -131 | 682 | 622 |
| Other Operating Activity | -68 | -120 | 10 | -193 | -233 |
| Operating Cash Flow | $-6,320 | $-4,171 | $-2,078 | $-6,903 | $-5,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -5 | -5 | -40 | -40 |
| Other Investing Activity | 1,400 | 1,400 | 1,400 | 0 | -12 |
| Investing Cash Flow | $1,387 | $1,395 | $1,395 | $-40 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 1,000 | 1,000 | 0 |
| Common Stock Issued | 7,869 | 7,869 | 184 | 3,080 | 3,080 |
| Financing Cash Flow | $8,869 | $8,869 | $1,184 | $4,080 | $3,080 |
| Beginning Cash Position | 777 | 777 | 777 | 3,640 | 3,640 |
| End Cash Position | 4,713 | 6,870 | 1,278 | 777 | 1,345 |
| Net Cash Flow | $3,936 | $6,093 | $501 | $-2,863 | $-2,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,320 | -4,171 | -2,078 | -6,903 | -5,323 |
| Capital Expenditure | -13 | -5 | -5 | -40 | -40 |
| Free Cash Flow | -6,333 | -4,176 | -2,083 | -6,943 | -5,363 |